DR. STUART A LIPTON, M.D./PH.D
Neurology at Gilman Dr, La Jolla, CA
License number
California G85439
Category
Neurology
Type
Neurology
Address
Address
2
9500 Gilman Dr, La Jolla, CA 92093
232410 Mail Code 0662, San Diego, CA 92193
232410 Mail Code 0662, San Diego, CA 92193
Phone
(858) 713-6261
(858) 713-6262 (Fax)
(858) 249-6749
(858) 713-6262 (Fax)
(858) 249-6749
Organization information
See more information about STUART A LIPTON at bizstanding.comStuart Lipton MD,PHD
9500 Gilman Dr #0662, La Jolla, CA 92093
Industry:
Neurologist
Phone:
(858) 713-6261 (Phone)
Stuart Arthur Lipton
Stuart A Lipton MD
9500 Gilman Dr, La Jolla, CA 92093
Categories:
Neurology Physicians & Surgeons, Psychiatry Physicians
Phone:
(858) 534-1501 (Phone)
Professional information
Dr. Stuart A Lipton, La Jolla CA - MD (Doctor of Medicine)
Specialties:
Neurology, Neuropsychiatry (Neurology)
Address:
UCSD Neurology Clinic
9350 Campus Point Dr STE B, La Jolla 92037
(858) 657-8540 (Phone)
9350 Campus Point Dr STE B, La Jolla 92037
(858) 657-8540 (Phone)
Certifications:
Neurology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Pennsylvania School Of Medicine
Graduated: 1977
Beth Israel Hospital
Harvard/Combined Programs
Harvard Med School
University Of Pennsylvania School Of Medicine
Graduated: 1977
Beth Israel Hospital
Harvard/Combined Programs
Harvard Med School
Stuart Arthur Lipton, La Jolla CA
Specialties:
Neurology
Work:
Perlman Medical Offices
9350 Campus Point Dr, La Jolla, CA 92037
9350 Campus Point Dr, La Jolla, CA 92037
Education:
University of Pennsylvania(1977)
Professor And Scientific Director At Burnham Institute For Medical Research
Location:
Greater San Diego Area
Industry:
Biotechnology
Stuart Stuart Lipton, San Diego CA
Specialties:
Neurology, Plastic Surgery
Work:
Ucsd Medical Group
200 W Arbor Dr, San Diego, CA 92103
200 W Arbor Dr, San Diego, CA 92103
Education:
The University of Texas at Houston (1985)
Stuart A Lipton, La Jolla CA
Specialties:
Neurologist
Address:
9500 Gilman Dr, La Jolla, CA 92093
Stuart Lipton, La Jolla CA
Specialties:
Plastic Surgeon
Address:
10901 N Torrey Pines Rd, La Jolla, CA 92037
591 West Main, Lewisville, TX 75057
591 West Main, Lewisville, TX 75057
Media Conditioned By Stem Cells And Uses Therefor
US Patent:
2011009, Apr 21, 2011
Filed:
Apr 7, 2010
Appl. No.:
12/756172
Inventors:
Stuart A. Lipton - La Jolla CA, US
Alexey Terskikh - La Jolla CA, US
Alexey Terskikh - La Jolla CA, US
International Classification:
A61K 35/12, A61Q 19/08
US Classification:
424520
Abstract:
Compositions for application to the skin of individuals in need thereof are provided that include media conditioned by the growth of human stem cells, particularly human neural stem cells. In some embodiments, the stem cells are grown without the use of feeder layers.
Neuroprotective Compositions And Methods
US Patent:
8466311, Jun 18, 2013
Filed:
Sep 19, 2011
Appl. No.:
13/236579
Inventors:
Stuart A. Lipton - La Jolla CA, US
Takumi Satoh - La Jolla CA, US
Takumi Satoh - La Jolla CA, US
Assignee:
Sanford-Burnham Medical Research Institute - La Jolla CA
International Classification:
C07C 61/29
US Classification:
562403, 562404
Abstract:
Neurite outgrowth-promoting prostaglandins (NEPPs) and other electrophilic compounds bind to Keap1, a negative regulator of the transcription factor Nrf2, and prevent Keap1-mediated inactivation of Nrf2 and, thus, enhance Nrf2 translocation into the nucleus of neuronal cells. Therefore, neuroprotective compositions and related methods are provided that employ such neuroprotective compounds, and prodrugs of such compounds, to cause dissociation of Nrf2 from a Keap1/Nrf2 complex.
Neuroprotective Compositions And Methods
US Patent:
8022246, Sep 20, 2011
Filed:
Oct 10, 2007
Appl. No.:
11/974114
Inventors:
Stuart Lipton - La Jolla CA, US
Takumi Satoh - La Jolla CA, US
Takumi Satoh - La Jolla CA, US
Assignee:
The Burnham Institute for Medical Research - La Jolla CA
International Classification:
C07C 61/29, A61K 31/19
US Classification:
562403, 562404, 514569
Abstract:
Neurite outgrowth-promoting prostaglandins (NEPPs) and other electrophilic compounds bind to Keap1, a negative regulator of the transcription factor Nrf2, and prevent Keap1-mediated inactivation of Nrf2 and, thus, enhance Nrf2 translocation into the nucleus of neuronal cells. Therefore, neuroprotective compositions and related methods are provided that employ such neuroprotective compounds, and prodrugs of such compounds, to cause dissociation of Nrf2 from a Keap1/Nrf2 complex.
Pathologically-Activated Therapeutics
US Patent:
2011017, Jul 14, 2011
Filed:
Jan 7, 2011
Appl. No.:
12/986746
Inventors:
Stuart A. Lipton - San Diego CA, US
International Classification:
A61K 9/127, G01N 33/53, C07K 16/00, G01N 33/573, C40B 30/04, A61K 39/395, A61P 25/28
US Classification:
424450, 436501, 5303871, 435 74, 506 9, 4241301
Abstract:
Disclosed are methods and compositions for identifying, producing, and using pathologically-activated targeting compounds. Pathologically-activated compounds are compound that only have an effect, or have a disproportionate effect, on a target molecule when a pathological condition exists.